We started with one question: what if supplements actually worked?
Amie began in 2019 as a small herbal supplement line — one formulation at a time, built around women's wellness. Ember for libido. Grace for menopause. Balance for cycle support. We weren't trying to be a telehealth platform. We were trying to make supplements that a clinician could look at without wincing — actual research-dosed ingredients, third-party tested, priced so a patient could actually afford to stay on them for the six months it takes to work.
That part worked. Customers stayed. Then they started asking for things we couldn't give them.
"I love Grace, but my hot flashes are severe and I need actual HRT — can you help?" "Ember has been great, but my libido issues are hormonal and I think I need prescription topical estrogen." "I've tried every herbal weight-loss product. My doctor won't prescribe a GLP-1. Can you help?" Hundreds of emails like these over five years. Our answer, every time, was some version of: that's outside our scope — talk to your doctor.
Except we watched their doctors fail them. Four-month waits. 7-minute visits. Insurance denials. Prescriptions that got stuck in pharmacy queues. Our herbal customers — capable, informed, motivated people — kept coming back to tell us they'd been labeled "non-compliant" for refusing to accept this.
So in 2025, we expanded. We brought on a medical review board, built out a network of licensed medical providers through partnered clinical networks, worked with licensed pharmacy partners, and launched our first prescription protocols: compounded semaglutide, bioidentical HRT, sexual wellness, and skin. Same patient-first posture as the supplement business. Same commitment that if something wasn't right for you, you'd get a real explanation and a real refund — not a ghost.
A year later, we've grown into what patients actually needed: a full-spectrum wellness company where a $29 bottle of Grace lives alongside a $179 compounded prescription, where your clinician and your supplement formulator work off the same intake, and where the answer to "can you help me?" is almost never "that's outside our scope."
We are, functionally, a small team building something boring: a medicine company that does the obvious things well. The obvious things are expensive and slow and don't scale the way the rest of telehealth does. We've decided that's fine. If we're the company patients tell their friends about because we actually helped them — and not because we had a viral ad — we'll be fine.
This is what we're building. Welcome.